Kestra Medical Technologies Inc

NASDAQ:KMTS

Kestra Medical Technologies Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington. The company went IPO on 2025-03-06. The firm is focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. The company has developed and commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform include the ASSURE WCD, a next generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The ASSURE WCD automatically monitors elevated risk patients and, if needed, delivers a defibrillation shock to return the patient’s heart to normal rhythm. In addition to the ASSURE WCD, its Cardiac Recovery System platform includes a comprehensive suite of fully integrated digital solutions and services.